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1. The Directive 2011/24/ EU: concept
Article 1 of  the Universal Declaration of  Human Rights (UDHR) states that all 
human beings are free and are endowed with rights, in conditions of  full equality and 
dignity. The principle of  equality is reinforced by provisions embedded in Articles 7 
and 10. The right of  access to health to all individuals without discrimination of  any 
kind is the ultimate expression of  respect for the dignity of  a human being.
The right to healthcare is enshrined in Article 25 (1) UDHR. It states that all 
persons are entitled to welfare achieved through access to sickness insurance, old 
age and disability.  Inspired by the vernacular of  the UDHR, the Convention on 
Human Rights and Biomedicine was created and ratified by the Portuguese State by 
Resolution of  the Portuguese Parliament. In this legal instrument, Articles 1, 2 and 
3 expressly establish access to healthcare in conditions of  equality and dignity, with 
a view to welfare and respect for the integrity and fundamental rights and freedoms 
of  the individual.
Under Article 4 (2) (k), in conjunction with precepts enshrined in Articles 6 
(a) and 168 of  the Treaty on the Functioning of  the European Union (TFEU), the 
EU has competence to legislate on public health, with the purpose of  safeguarding 
the common security of  Member States by implementing measures that will strive 
to minimize the impact of  illness and disease on the economies of  EU Member 
States. In this vein, it is for the EU to strive for the adoption of  political, legal and 
administrative measures for, inter alia, health information and education, surveillance1 
dedicated to serious threats and risks to public health. Based on this concern, the 
Directive 2011/24/EU of  the European Parliament and of  the Council of  9 March 
2011 on the exercise of  patients’ rights in cross-border healthcare is developed.
The notion of  cross-border healthcare identifies with the mobility of  patients, 
including the provision or prescription of  healthcare in a Member State other than the 
Member State of  affiliation, being designated by the Directive as “Member State 
of  treatment.” In fact, this Directive calls cross-border healthcare the situation in which 
the patient takes medicine and medical devices in a Member State other than the 
Member State of  affiliation, as well as the situation in which the patient gets these 
medication and medical devices in a Member State other than that in which the 
prescription was issued.2
According to Article 3 (a) under the heading “Definition”, it is understood by 
healthcare, health services provided by health professionals,3 including the prescription, 
dispensation and provision of  medicines and medical devices. On the other hand, in 
accordance with Article 3 (e), cross-border healthcare is the one provided or prescribed 
in a Member State other than the Member State of  affiliation. In other words, in a 
State from the European area different from the State of  the citizen in which the 
patient is a resident, insured, or where he is entitled to sickness benefits under the 
law of  that Member State.
The primary aim of  the Directive is to prevent the States from imposing 
1 In particular on the monitoring of  threats and warning of  health risks to public health, see Sara 
Vera Jardim and Diana Grilo, “A União Europeia e as políticas de Saúde em Portugal”, in 40 Anos de 
Abril na Saúde, Coimbra: Almedina, 2014, 337 ff. 
2 See paragraph 16 of  the Directive. 
3 For the purposes of  this Directive, a health professional is qualified as a doctor, nurse, dentist, 
midwife or even a pharmacist or other professional whose activity in the health sector is a regulated 
profession, such as a psychologist, physiotherapist, etc. [see paragraph f) of  Article 3 of  the Directive]. 
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restrictions on the freedom to provide medical services in the European Union area, 
ensuring that a patient could choose to receive the health service that is in another 
Member State.4 In this sense, it seeks to provide access to healthcare to patients 
of  the Member States on security and quality conditions, allowing their mobility 
within Europe. Also, it promotes collaboration between Member States regarding 
the definition of  social security benefits relating to health and the organization and 
delivery of  healthcare and medical care as well as other benefits related to the disease.5
The Court of  Justice of  the European Union (hereinafter, CJEU) has contributed 
significantly to this legislative progress, in the path of  the attempt to resolve the issue 
on the reimbursement of  healthcare costs incurred in another Member State. The 
jurisprudence of  this Court has always striven for the defense of  freedom of  the 
provision of  services and movement of  goods, inter alia. 
Among the solutions mentioned in the Directive, we can highlight the following: 
(i) the provision of  health care is covered by the scope of  protection as the freedom 
to provide services; (ii) the Directive has affixed a broad meaning to “the provision 
of  healthcare” and what acts that it comprises. This can include, inter alia, providing 
specialized care (in hospitals) and undifferentiated (primary care, but no long-term 
care); (iii) the freedom to provide medical services include the very freedom of  
the service recipients (i.e. the patients) to go to another Member State to receive 
the same; (iv) the right to be treated equally in another Member State exists both 
in the universal public health system (in the case of  the Portuguese system) and 
in health systems based on private insurance; (v) it remains the prerogative of  the 
Member States to organize their individual social security and health systems; (vi) 
it may exceptionally be admitted a prior authorization mechanism for States – as a 
rule is seen as an impediment to the freedom to provide services – on grounds of  
“compelling reasons in the public interest.”6
The Directive clearly states that patients, who decide to seek treatment in 
another Member State other than that of  affiliation, should not be denied access 
to them, except in certain circumstances relating to the public interest. There may be a 
number of  reasons why a Member State might wish to evoke this safeguard: (i) first, 
the risk to public health,7 emerging from doubts about how to proceed with infectious 
diseases, assuming that they are excluded from the range of  medical procedures 
being performed in another Member State; (ii) second, the risk of  financial collapse of  
the health system of  the “host” State, which seems likely evocable by most Member 
States, because the public expenditure with the health sector is high. There are 
medical and surgical treatments that may involve excessive structural planning and 
sophisticated infrastructure by the States, justifying the refusal to accept patients 
who cast doubt on the sustainability of  the health system of  the Member State of  
treatment.
1.1. The scope of  application and restrictions
The provision and prescription can take place in health facilities, public and 
private. These are included in all health care, public and private, regardless of  how 
4 See Maria João Estorninho and Tiago Macieirinha, Direito da Saúde. Lições, Lisboa: Universidade 
Católica Portuguesa Publisher, 2014, 282. 
5 See paragraph 10 of  the Directive. 
6 See Maria João Estorninho and Tiago Macieirinha, Direito da Saúde, Lições, cit., 283. 
7 See paragraphs 11 and 12 of  the Directive. 
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it is organized, delivered and financed.8 It also includes prescribing, dispensing and 
supplying medicines and medical devices.
The scope and objective of  this Directive is to provide health care as defined by 
Article 1 (1), in conjunction with Article 3 (a). However, there are restrictions under 
the precept embedded in Article 3 (3). First, in the case of  continuing or supportive 
care, i.e. support for patients in their daily lives, in the minimum hygiene care, home-
based, usually provided at home or in nursing homes. Second, the transplants are 
excluded from the scope of  cross-border healthcare, as a result of  the particular 
complexity around the collection and allocation of  organs. Finally, public vaccination 
programs against infectious diseases which are intended to protect only the health of  
the population of  a given Member State.
2. Obligations of  Member States
2.1. Member States of  treatment
From this Directive results – in the legal sphere of  the Member State of  
“treatment” understood as that State in whose territory healthcare is actually provided 
to the patient9 – a significant number of  certain positive and negative obligations.
In the terms established by Article 4, the following tasks belong to the Member 
State of  treatment. First, the provision of  clear, objective and relevant information 
that allows the patient to decide whether to opt for the use of  the provision of  
health care in that State. This should be about standards and guidelines on quality 
and safety, such as those relating to monitoring, evaluation of  health care providers 
and the accessibility of  hospitals for persons with disabilities.10
Another obligation placed on the Member State of  treatment is to give patients 
access to appropriate complaint procedures that are transparent and provide them 
with the opportunity to voice any grievance(s) they may have if  they suffer harm 
resulting from the healthcare they have received.11
The Member State in which healthcare is provided is also required to ensure 
the existence of  a professional liability insurance or other guarantees to safeguard 
damage and risks to health and physical integrity of  the patient.12
On the other hand, recognition and zeal for the right to privacy of  personal 
data, as well as ensuring continuity of  care associated with clinical and computer 
records of  the treatment carried out, are priorities to be considered.13
Treatment in conditions of  non-discrimination, in accordance with the 
principles of  universality, quality, equity and solidarity are key obligations for which 
the State of  treatment should guide their actions.
One manifestation of  the principle of  equality or of  non-discrimination 
on grounds of  nationality between nationals and non-nationals patients is the 
application of  pre-set scale of  charges to comparable medical conditions or similar 
clinical conditions. 
However, the Directive itself  has a proviso: “Taking into account all mentioned herein 
duties, it is not undermined or restricted the possibility of  the Member-State of  treatment to adopt 
8 See Sara Vera Jardim and Diana Grilo, “A União Europeia e as políticas de Saúde em Portugal, cit. 356. 
9 See Article 3, paragraph d) of  the Directive. 
10 See Article 4(2) (a) and (b) of  the Directive. 
11 See Article 4(2) (c) of  the Directive. 
12 See Article 4(2) (d) of  the Directive. 
13 See Article 4(2) (e) and (f) of  the Directive. 
® UNIO - EU LAW JOURNAL Vol. 2,  June 2016
101 Isa António
measures concerning the treatment...and avoid as much as possible, the waste of  financial, technical 
and human resources. Such measures should be (yet) limited to what is necessary and proportionate 
and may not constitute a mean of  arbitrary discrimination.”14 In fact, the Directive sets a 
limit of  proportionality and reasonableness, related to the principle of  financially 
possible, serving as a safeguard clause to the enforcement and implementation of  the 
obligations imposed as it may be seen as too costly for the Member State concerned.
2.2. Member State of  affiliation
The competent State to authorize the insured persons15 to receive treatment outside 
the Member State of  residence is called the “Affiliate Member State”. According 
to the regulations of  coordination of  social security systems, it has the following 
obligations. First, the repayment obligation of  the amounts related to the costs 
of  cross-border healthcare [Article 5 (a)], together with the duty of  information 
on patients’ rights related to receiving cross-border healthcare including on the 
reimbursement of  costs.16
The State of  Affiliation should also guarantee medical follow up to patients 
that receive cross-border care when this is required, as it would have been if  the 
healthcare had been provided on its territory.17 Furthermore, it is also imperative that 
they ensure that all their patients, in obtaining cross-border healthcare, have access 
to their medical records.18
It is important to point out that the State of  Affiliation is bound to pay the 
reimbursement of  the costs of  health care, only in the exact terms that they would 
have if  these medical procedures were performed in their territory. It will never have 
to pay the excess of  the actual costs of  care received.19 But in some cases, it may 
decide to pay the costs of  travel and accommodation.20
The obligation to repay the costs of  medical care has exceptions contemplated in 
Article 7 (9) and Article 8, by being subject to prior authorization. This authorization 
has generated some reservations and earned criticism, including by the Health 
Regulatory Authority,21 but we will not focus on this issue, because it is not the 
subject of  this study.
3. The specific case of  “medical error”
We believe that “medical error” is any kind of  lack of  compliance in the 
performance of  a medical procedure, either by action or omission, characterized by 
the violation of  the leges artis ad hoc medicinae22 (understood as a set of  clinical guidelines 
14 See Article 4(1) and (3) of  the Directive. 
15 According to Article 3, (b) of  the Directive, “insured person” includes the person, but also 
members of  his family and his survivor, covered by Article 2 of  the EC Regulation No. 833/ 2004 
and third-country nationals covered by Regulation EC No. 859/2003 or that fulfill the conditions 
laid down in the laws of  the State member of  affiliation regarding the entitlement to benefits. 
16 See (Article 5, paragraph b) read in conjunction with Article 7, No. 6). 
17 See Article 5(c) of  the Directive. 
18 See Article 5(d) of  the Directive. 
19 See Article 7 paragraphs 3 and 4 of  the Directive. 
20 See Article 7(4) of  the Directive. 
21 See in detail the opinion of  the Health Regulatory Authority on the Directive No. 2011/24/EU 
of  the European Parliament and of  the Council of  9 March 2011. 
22 ‘Leges artis ad hoc medicinae’ refers to those rules by which the health professionals would have 
to guide themselves in the development of  their activity: particularities of  medical activity, multiple 
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that the current state of  the art of  medicine and science impose as the most 
appropriate and more reliable, applicable to a given clinical condition at a particular 
time of  technological advancement and knowledge).
In turn, we can define generally “medical act” as follows: “It is all the direct or indirect 
action on a human body by a physician (or medical staff) in the exercise of  their profession, to which 
has proper academic university degree in medicine and surgery...”23 Alfonso de la Osa gives us 
the definition of  “medical procedure” which is “…an act performed by a doctor whose purpose, 
directly or indirectly, promote or ensure the conditions for human health and which generally has 
an effect on the human body.”24 We believe that this concept should be upheld as the 
standard reference to define, in turn, what is meant by “medical error” in the light of  
Directive 2011/24/EU on cross-border healthcare.
By virtue of  the existence of  “medical errors” happening during the execution 
of  cross-border healthcare, the aforementioned Directive states25 that there must be 
clear obligations for providing mechanisms to respond to harm resulting from the 
carriage of  health care in order to prevent the lack of  confidence in those mechanisms 
by the patient which could result in an obstacle to the use of  cross-border healthcare.
National legislation of  each Member State on the liability for damages caused 
in the exercise of  medical activity cannot limit the extension of  coverage of  national 
health systems to patients from their country wishing to receive healthcare abroad, 
whenever this is the more appropriate mean to address the clinical condition of  the 
patient.
In this vein, Member States should ensure protection regimes of  patients and 
compensation in case of  injury or loss of  health care provided in their territory. 
The legal system of  each Member State shall, if  necessary, be subject to a legislative 
amendment in order to adapt to the risk, in terms of  extent and nature.26 However, 
it is always the exclusive prerogative of  States to determine the characteristics and 
modalities of  such legal liability regimes for medical procedures caused by cross-
border healthcare.
We raise, in this regard, the following question: in case of  medical error, resulting 
in damage to health, life, physical integrity or patient safety, which national legislation 
should apply? How and on what terms can the patients demand compensation for 
factors that influence it, the complexity of  their interventions, the relevance at a given time of  the 
patient´s treatment, etc. Thus, it is understood by ‘leges artis ad hoc medicinae’, the application of  general 
medical rules to the same or similar cases to ensure an objective performance with due care. It can still 
be regarded as the evaluative criterion of  correctness of  one determined medical procedure performed 
by a medical professional (science or medicine) that takes into account the particularities of  its author, 
profession, complexity of  its activity and expertise, as well as external factors as it is the particular 
condition of  the patients, the potential involvement of  their families, the hospital organization and 
sanitary conditions, etc. to qualify the medical procedure in question as consistent or inconsistent with 
the required technique (taking into account the legitimate requirements and lawful medical action, the 
effectiveness of  performed proceeding, and the possible responsibility of  the author-physician as a 
result of  its intervention). See Isa António, A responsabilidade da Administração Pública por atos médicos, 
Master’s thesis, Catholic University of  Porto, 2008, 95. See also José María González and Andrea 
Macía Morillo, “La responsabilidad médica en el ordenamiento español”, in Responsabilidade civil dos 
médicos, Centro de Direito Biomédico da Faculdade de Direito da Universidade de Coimbra, No. 11. 
Coimbra: Coimbra Editora, 2005, 44 e 45. 
23 See Pedro Rodríguez Lopez, Responsabilidad médica y hospitalaria, Bosch, 2004, 34 and 35. 
24 See Alfonso Lopez de la Osa Escribano, La convergence de la responsabilité hospitalière en France et en 
Espagne. Étude compare, Marseille: Presses Universitaires d’Aix, 2005, 232 et seq. 
25 See paragraph 23 Directive 2011/24/EU.
26 See paragraph 24 of  the Directive 2011/24/EU. 
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their damages for cross-border healthcare? What legal mechanisms are at their 
disposal? 
The patient may, in our view, resort to legal mechanisms for the recovery 
of  their legal status in status quo ante to injury in the following ways: First, he can 
use the mechanisms at his disposal entitled by his European citizenship, via the 
European Ombudsman (Article 228 TFEU), by lodging a complaint under which 
all the relevant facts are exposed. The European Ombudsman will, then, conduct 
a phase of  investigation or inquiry, checking with the Member State of  treatment, 
the accuracy of  the facts set out by the patient. If  it is considered that the facts 
submitted have grounds, the Ombudsman will decide to forward the case to the 
European Commission. In the exercise of  its functions, as guardian of  the Treaties 
and caretaker of  good compliance with European law, it may bring the competent 
action for failure (Articles 258 to 260 TFEU) against the non-compliant State of  
the treatment. The European Ombudsman may alternatively decide to refer this 
situation immediately to the CJEU if  it considers that the facts are lined with obvious 
seriousness and difficult voluntary return by the offending Member State.27
Another hypothesis that may be added to the previous one is the admissibility 
of  the Affiliated Member State to bring, in itself, a contentious case before the CJEU 
against the Member State of  treatment on grounds of  discrimination and denial of  
their national as sick, for unqualified and insufficient treatment, or for disregarding the 
collaboration rules established by the Directive. The Member State of  Affiliation files, 
prior to the legal action, a well-grounded complaint to the European Commission,28 
in order to attempt an amicable, expeditious and efficient settlement of  the situation 
with the offender Member State of  treatment. 
The pleas put forward in both judicial proceedings before the CJEU as well as 
with the European Commission may be of  various kinds, such as: i) the disregard for 
fundamental principles: the principle of  non-discrimination on grounds of  nationality, 
the principle of  equality, the principle of  solidarity, principles of  universality and 
equity in access to health care; ii) violation of  Treaties (primary or originating 
legislation), particularly the Charter of  Fundamental Rights of  the European 
Union and the TFEU;29 iii) violation of  the Directive on cross-border healthcare 
(secondary legislation); iv) violation of  citizen rights, while “sick”, such as health, 
life, psychological integrity, security, medical and health “hygienic and healthy” 
environment, respect, protection of  private intimacy, personal data protection, etc.
Assuming that the State of  treatment is Portugal, the legal regime of  Law 
67/2007, of  December 3130 applies, whether by active conduct (for action) or negative 
27 We believe that the legal action before the CJEU should be the last resort in the activities of  
the European institutions, in order to assign only situations with legal significance to this court, 
under penalty of  contributing to the slow pace of  European justice and the subordination of  the 
European judges to matters of  minor importance. Moreover, the route of  amicable settlement, 
by giving the opportunity to the offending Member-State to redeem itself, restoring the legality 
or compensating the damages, contributes to a higher level of  trust, collaboration and inter-state 
diplomacy, along with more efficient and expeditious settlement of  disputes. 
28 See João Mota de Campos/João Luiz Mota de Campos, Manual de Direito Europeu. O sistema 
institucional, a ordem jurídica e o ordenamento económico da União Europeia, 6th ed. Coimbra: Coimbra 
Publisher, 2010, 443 et seq. 
29 Miguel Gorjão-Henriques, Direito da União. História, Direito, Cidadania, Mercado Interno e Concorrência, 
6th ed,. Coimbra: Almedina Bookshop, 2010, 307 et seq, as well as, João Mota de Campos/João 
Luiz Mota de Campos, Manual de Direito Europeu, cit., 345 et seq. 
30 Extra-contractual Civil Liability Act of  the State and other public entities. 
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(by omission, abstention) from which results a loss or injury, property damage and/ 
or personal injury. Therefore, on a second level, a patient injured abroad, due to 
cross-border health care in public health facilities in Portuguese territory, use the 
means made available by the Portuguese State, with a view to fair and adequate 
compensation.
Regarding the healthcare liability of  hospitals, one will have to consider not only 
the nature of  the act in question but also a myriad of  factors such as the qualification 
of  the agent, the legitimacy of  its action, the legality and appropriateness of  delegation 
entrusted, the difficulty and urgency of  the intervention itself, the existent material, 
personal and organizational means, etc.
More specifically, it is crucial to consider that, except for cases of  urgency or 
duly justified of  proven force majeure, technical personnel and medical students shall 
only perform a medical act, no matter how easy or complex it may be,  under the 
direct and effective monitoring and responsibility of  the Director, head of  service 
or head of  the medical team, or by delegation expressed or implied, and provided 
that with such intervention the “medical guarantees” of  patients are not violated or 
disregarded. The assessment regarding the risk and skills and practical experience 
of  the involved agents already would be, in itself, a “medical procedure”, and therefore 
part of  the diagnostic or therapeutic. As such, this part should also be examined by 
the courts for the purposes of  responsibility within the general principles laid down 
aiming at reconciling patients’ rights, proper training of  medical and paramedical 
personnel, as well as the demands of  medical progress.31
In our view, without disregarding the application of  individual or collective 
criminal and disciplinary action to the doctor, medical team or other health professional, 
the liability regime against public and private institutions that are part of  the legal 
relationship for providing health care to the patient would also apply.32 According to 
a certain doctrine, the most appropriate legal institution to respond to disputes arising 
out of  medical errors is the Extra-contractual Civil Liability [“...the violation of  legal health 
requirements can also be a source of  aquilian liability or non-contractual liability, since the rights 
concerned...are…absolute rights...”].33 On the contrary, there are other doctrinal positions 
such as Sinde Monteiro’s who advocates the contractual liability as the most appropriate 
institution, whether at stake is a public or private institution.34
Any hospital service must act with care and diligence appropriate to the 
particular situation of  its users, under the penalty of  being guilty for dismissing 
this legal obligation and by consequently causing damage to their patients, having 
the public hospital to compensate them when the following cumulative conditions 
are present:35 volunteer fact, illegality, guilt (intent or negligence), injury, causal link 
between the act committed or omitted, and the damage or injury specifically suffered 
by the patient.
On the other hand, by having the status of  “respect of  public service”, the public 
hospital incurs in an extra-contractual nature of  liability, consequently responding 
31 See Isa António, A responsabilidade da Administração Pública por atos médicos, cit., 87-88. 
32 See Maria João Estorninho/Tiago Macieirinha, Direito da Saúde. Lições, cit., 293 and 294. 
33 Idem. 
34 On this subject see Nuno Pinto Oliveira, “Responsabilidade civil em instituições privadas de saúde: 
problemas de ilicitude e de culpa”, in Responsabilidade civil dos médicos, Centro de Direito Biomédico da 
Faculdade de Direito da Universidade de Coimbra, Coimbra: Coimbra Editora, 2006, 142.
35 See Maria João Estorninho and Tiago Macieirinha, Direito da Saúde, Lições, cit., 295 to 302. 
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under Law No. 67/2007,36 in situations where Portugal is the Member State of  
treatment. Paragraph 1 of  Article 11, Law No. 67/ 2007 states the following: “The 
State and other legal persons governed by public law are liable for damage arising from activities, 
things or especially dangerous administrative services....”
We advocate the position that medical activity is a particularly dangerous activity, 
given the abnormal and special risks, the specificities of  the service itself  and the 
organization of  health facilities, combined with the characteristics of  each human 
body or the disease itself. Therefore, medical liability caused by cross-border 
healthcare should dismiss the assumption of  “guilt”37 and require only the objective 
inconsistency of  the performed care with clinical standards and leges artis ad hoc 
medicinae, and the relationship between the volunteer event and the injury suffered.
We welcome the ruling doctrine that advocates the objectivity trend of  State´s 
civil liability, reflected in the statement of  Carla Amado Gomes: “The scheme approved 
by Law No. 67/2007, of  31 December, implementing Article 22 of  the Portuguese Republic 
Constitution, points to a mixed model of  administrative responsibility function, which, while 
maintaining the route of  subjective accountability, considerably widens the lens of  accountability 
and quite tinting the first.”38
Especially in regard to medical activities in public establishments providing 
health services their main purpose is to drive the proper performance of  the leges 
artis ad hoc medicinae and a strict conduct, with the diligence of  the criterion of  the average 
man as referred to in Article 487, paragraph 2 of  the Civil Code, which is also adopted 
in the context of  administrative activity.
According to the provision of  article 4, paragraph 1, Law No. 52/2014 of  
August 25 – which transposes the Directive 2011/24/EU and Directive of  
Execution 2012/52/EU39 – cross-border healthcare is provided in accordance with 
the principles of  universality, access to quality health care, equity and solidarity in 
compliance with national legislation standards on quality and safety of  the Member State of  
treatment and according to EU legislation on the safety standards.
Therefore, when the Member State of  treatment is Portugal and an injury or 
property or material damage is caused, by virtue of  “medical error” in cross-border 
health care in compliance with the Directives mentioned, Portuguese law shall apply 
in order to compensate the patient. The legal regime of  non-contractual liability of  
the State and other public entities, enshrined in Law No. 67/ 2007 – liability for the 
risk form – will be therefore applicable, notwithstanding EU law on the violation of  
security rules associated with medical care and the structural principles of  equality, 
non-discrimination on grounds of  nationality, solidarity and rights as enshrined in 
the Charter of  Fundamental Rights of  the European Union.
36 However, it was revised by Law No. 31/2008, of  17 July. 
37 On this topic see Carla Amado Gomes, “A responsabilidade civil extracontratual da 
Administração pelo risco: uma solução arriscada?”, in Textos dispersos de direito da responsabilidade civil 
extracontratual das entidades públicas, Lisbon, 2010, 83 ff. 
38 See Carla Amado Gomes, “Nota breve sobre a tendência de objectivação da responsabilidade civil 
extracontratual das entidades públicas no regime aprovado pela Lei 67/2007, de 31 de Dezembro”, 
in Responsabilidade Civil do Estado, Centre for Judicial Studies, Lisbon: July 2014, 83, consulted in 
January 2016: http://www.cej.mj.pt/cej/recursos/ebooks/civil/Responsabilidade_Civil_Estado.pdf.
39 See Implementation Directive 2012/52/EU of  the European Commission of  20 December 2012 
on measures to facilitate the recognition of  prescription issued in another Member State. 
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4. Critical reflection on the weaknesses of  the healthcare 
transboundary
We consider the “right to health”, and its universal access in terms of  quality 
and equity, a true integral human right and a sine qua non of  citizenship.40
The legal protection provided by this right is of  universal significance and 
results from the spirit of  the fundamental law of  all Western European countries, 
the Universal Declaration of  Human Rights, the UN Charter, and the Charter of  
Fundamental Rights of  the European Union (hereinafter, CFREU). The Directive 
2011/24/EU shows the concern of  European countries with this human right and 
the difficulties with the implementation and enforcement of  these provisions. 
In any case, it is important to take a critical reflection on the weaknesses 
of  the healthcare transboundary due to the risks that it entails. States with better 
conditions could be submerged with clinical cases stemmed from countries where 
the health system does not have as much quality and where there are many waiting 
lists. Moreover, we could see an increase in waiting times of  the patients in the host 
countries, where they previously did not exist, associated with more acute problems 
in health systems, due to the increase of  patients from other countries.
There is a danger of  encouraging “health tourism” due to the induction of  
demand for medical services in the Member State of  treatment, that is to say, the risk 
of  hospitals tending to prescribe all kinds of  treatment, tests or perform surgery or 
other medical acts, increasing the invoice of  the State of  origin/affiliation. Cross-
border health care may come to be regarded by Member States as a source of  income 
via “export of  medical services” or a way of  boosting their national economy, as it 
is the case with “tourism”.
It seems only essential to acknowledge the danger of  this resulting in a “disincentive” 
for improving the health system of  the various Member States, since they might fear to 
become too attractive for patients. The issue of  financial sustainability of  the Member 
States’ health systems and social security, due to the increase of  health care costs and 
the consequent rise in the public deficit of  the Member States of  affiliation, which 
must reimburse patients, may also be a cause of  concern.
Moreover, there is the considerable danger of  adverse selection leading to 
the possible “refusal” and “discrimination” of  the more expensive patient, whose 
pathology ensures “less financial return”. Associated with this risk there is also a 
possibility of  asymmetry regarding the information exchanged among the various 
Member States with regard to their health systems, equally harmful to the universal 
and equitable access patients have to health.
According to our understanding, the question about the contours of  medical 
liability is undoubtedly the one that raises more challenges on this subject: how to 
ensure the liability of  health facilities in which “medical errors”, either by action or 
by omission, occur? As mentioned above we defend the theory of  “strict liability” or 
“based on risk” in terms of  the non-contractual civil liability of  the Member States 
in hospital matters or “medical procedures” on the ground that it is very difficult for 
the patient to prove guilt and the causality nexus between the fact and the damage 
suffered by him, when considering the specificities of  the medical science. In the 
context of  liability for “medical errors” caused by cross-border healthcare, medical 
40 See Isa António, As parcerias público-privadas no sector da Saúde, Coleção Teses, Coimbra: Almedina, 
2015, 64 ff. 
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liability should be based on “‘présomption de faute’,41 similarly to what is done in France 
by means of  the reversal of  the burden of  proof  in favor of  the patient.
In turn, it becomes imperative to implement a strong independent regulation42, 
at the supra-State level, European-oriented and able to oversee issues relating to 
competition within the activities of  insurers and private providers. In view of  the 
above, in our opinion it appears that there is a need to create a European mediation 
centre dealing exclusively with proceedings related to medical liability or to other 
disputes arising from the practice of  cross-border health care. To overcome this 
problem, it would be useful to set up inter-state conciliation boards, in case of  dispute 
or disagreement over the terms of  the application of  medical care to their nationals, 
or on the “price” applied in a particular case. Despite there being pre-fixed price 
lists, it is always likely that the dissonance about their application or interpretation on 
the need to have brought that particular medical procedure to the patient may raise 
questions or disputes. By this order of  reasons, the articulation and dialogue between 
the European Commission and/or hypothetical Regulatory European Health 
Authority and the national health regulatory authorities is imperative to achieve the 
goals of  the Directive.
Finally, while praising the commendable objectives of  this EU Directive, imbued 
with the spirit of  true solidarity and respect for the human right of  access to health, 
we cannot fail to note our reservations about its problematic application, which raises 
complex legal and financial dilemmas. In our view, it has indeed revealed the absolute 
need for the institutionalization of  a High Authority for the Regulation and Supervision 
in the “European Health System,” now harmonized by the Directive 2011/24/EU of  
the European Parliament and of  the Council of  9 March 2011, on the exercise of  
patients’ rights in cross-border healthcare, and the implementing Directive of  execution 
2012/52/EU of  the Commission of  20 December 2012 on measures to facilitate the 
recognition of  medical revenue issued in another Member State.
41 See Alfonso Lopez de la Osa Escribano, La convergence de la responsabilité hospitalière en France et en 
Espagne, cit., 232 et seq. 
42 AAVV, “A Reforma do Sector da Saúde. Uma realidade iminente?”, Institute for Economic and 
Financial and Tax Law. Coimbra: Almedina, 2010, as well as Rui Nunes, Regulação da Saúde, 3rd 
edition, Porto: Economic Life, 2014. 
